AU4790597A - Process for the extraction of proteins - Google Patents

Process for the extraction of proteins

Info

Publication number
AU4790597A
AU4790597A AU47905/97A AU4790597A AU4790597A AU 4790597 A AU4790597 A AU 4790597A AU 47905/97 A AU47905/97 A AU 47905/97A AU 4790597 A AU4790597 A AU 4790597A AU 4790597 A AU4790597 A AU 4790597A
Authority
AU
Australia
Prior art keywords
extraction
proteins
disaggregating
homogenised
dissociating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47905/97A
Inventor
Siri Dale
Magne K. Fagerhol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda AS
Original Assignee
Nycomed Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26310325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU4790597(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9622839A external-priority patent/GB9622839D0/en
Priority claimed from GB9707148A external-priority patent/GB9707148D0/en
Application filed by Nycomed Pharma AS filed Critical Nycomed Pharma AS
Publication of AU4790597A publication Critical patent/AU4790597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805—Haemoglobins; Myoglobins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Extraction Or Liquid Replacement (AREA)

Abstract

The present invention provides a process for the extraction of proteins from gastrointestinal tract samples taken from humans or other mammals wherein the sample is mixed with an excess amount of aqueous extraction medium comprising at least one dissociating, disaggregating and/or chelating agent, homogenised in a closed vessel, the solid and liquid materials of the dispersion are separated from each other and the clear liquid extract is recovered.
AU47905/97A 1996-11-01 1997-11-03 Process for the extraction of proteins Abandoned AU4790597A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9622839 1996-11-01
GB9622839A GB9622839D0 (en) 1996-11-01 1996-11-01 Process
GB9707148 1997-04-08
GB9707148A GB9707148D0 (en) 1997-04-08 1997-04-08 Process
PCT/GB1997/003013 WO1998020355A1 (en) 1996-11-01 1997-11-03 Process for the extraction of proteins

Publications (1)

Publication Number Publication Date
AU4790597A true AU4790597A (en) 1998-05-29

Family

ID=26310325

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47905/97A Abandoned AU4790597A (en) 1996-11-01 1997-11-03 Process for the extraction of proteins

Country Status (12)

Country Link
US (1) US6225072B1 (en)
EP (1) EP0937259B1 (en)
JP (1) JP4105768B2 (en)
AT (1) ATE278964T1 (en)
AU (1) AU4790597A (en)
CA (1) CA2268926A1 (en)
DE (1) DE69731103T2 (en)
DK (1) DK0937259T3 (en)
ES (1) ES2225956T3 (en)
NO (1) NO326302B1 (en)
PT (1) PT937259E (en)
WO (1) WO1998020355A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0229747D0 (en) 2002-12-20 2003-01-29 Axis Shield Asa Assay
ATE521894T1 (en) * 2007-11-20 2011-09-15 Hoffmann La Roche METHOD FOR ASSESSING COLORECTAL CANCER USING A Stool Sample USING A MARKER COMBINATION OF CALPROTECTIN AND A HEMOGLOBIN/HAPTOGLOBIN COMPLEX
JP2012507723A (en) * 2008-11-03 2012-03-29 シェーリング コーポレイション Inflammatory bowel disease biomarkers and related treatment methods
EP2202320A1 (en) 2008-12-24 2010-06-30 Agendia B.V. Methods and means for typing a sample comprising colorectal cancer cells
US20130164776A1 (en) 2009-11-23 2013-06-27 Lars Olof A Hansson Method used in a human or animal faeces sample processing system, and a sample processing system
NO336551B1 (en) 2011-06-21 2015-09-28 Magne Fagerhol Improved ELISA for calprotectin in faecal or gastrointestinal tract test
NO20110895A1 (en) 2011-06-21 2012-12-24 Magne Fagerhol Competitive S100A9 immunoassays
WO2013132338A2 (en) 2012-03-06 2013-09-12 Calpro As Competitive immunoassay for calprotectin
WO2013132347A2 (en) 2012-03-06 2013-09-12 Calpro As Improved elisa immunoassay for calprotectin
DK2947459T3 (en) 2014-05-21 2017-10-23 Bühlmann Laboratories Ag Method for Determining a Protein
CN108290058B (en) 2015-09-17 2023-05-16 美国安进公司 Predicting clinical response of IL23 antagonists using IL23 pathway biomarkers
AU2016379157A1 (en) 2015-12-22 2018-06-21 Amgen Inc. CCL20 as a predictor of clinical response to IL23-antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8318754D0 (en) 1983-07-11 1983-08-10 Fagerhol M K F Human proteins anti-sera test kits
EP0281251A3 (en) * 1987-02-04 1988-09-28 International Immunoassay Laboratories, Inc. A method for preparing a fecal sample composition for immunoassay testing
US5139934A (en) * 1990-05-25 1992-08-18 Becton, Dickinson And Company Substrate composition and method for solid phase urease immunoassay
US5455160A (en) * 1993-05-27 1995-10-03 Fagerhol; Magne K. Diagnostic test and kit for disease or disorders in the digestive system

Also Published As

Publication number Publication date
DE69731103T2 (en) 2005-11-17
ES2225956T3 (en) 2005-03-16
EP0937259A1 (en) 1999-08-25
JP4105768B2 (en) 2008-06-25
NO326302B1 (en) 2008-11-03
CA2268926A1 (en) 1998-05-14
WO1998020355A1 (en) 1998-05-14
NO992099L (en) 1999-04-30
DE69731103D1 (en) 2004-11-11
US6225072B1 (en) 2001-05-01
JP2001503863A (en) 2001-03-21
ATE278964T1 (en) 2004-10-15
EP0937259B1 (en) 2004-10-06
NO992099D0 (en) 1999-04-30
DK0937259T3 (en) 2005-01-31
PT937259E (en) 2005-01-31

Similar Documents

Publication Publication Date Title
AU4790597A (en) Process for the extraction of proteins
WO1999042839A3 (en) Treating cancer
AU5579099A (en) Electrochemical affinity assay
CA2181190A1 (en) Mesoscale Sample Preparation Device and Systems for Determination and Processing of Analytes
AU5794498A (en) Releasable nonvolatile mass-label molecules
CA2263888A1 (en) Methods and compositions for the detection of cervical cancer
CA2143999A1 (en) Device and method for combined bioaffinity assay and electrophoretic separation
CA2285918A1 (en) Methods for concentrating ligands using magnetic particles
GB9709728D0 (en) Single step method
CA2206760A1 (en) Reagent preparation containing magnetic particles in tablet form
WO2000020846A8 (en) Method for imaging tissue
CA2413978A1 (en) Multianalyte molecular analysis
HK1008442A1 (en) Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction
CA2333852A1 (en) A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)
CA2133560A1 (en) Hair analysis method
EP0803577A3 (en) Method for detecting and/or determining ATP from microorganism cells in a sample
WO2001055708A3 (en) Method of processing a sample containing at least one biological element
EP1767629A3 (en) Methods for the detection, analysis and isolation of nascent proteins
AU3527395A (en) Assay method
EP0935754A4 (en) Compositions and methods for detection of antibody binding to cells
EP0974841A3 (en) Suppression of interference in immunoassays using substances derived from the framework regions of antibodies
AU4553296A (en) Method and reagent for the specific determination of LDL in serum samples
AU4943496A (en) Process and compounds for detection of analytes using remanence measurement, and use thereof
AU3088795A (en) Novel polypeptides
AU8540098A (en) Device for taking and examining samples

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period